李氏大藥廠：2023年年報.pdf

1、2023ANNUAL REPORT(incorporated in the Cayman Islands with limited liability 於開曼群島註冊成立之有限公司)(Stock Code 股份代號:950)*For identification purpose only 僅供識別年 報CONTENTS目 錄Corporate Information2公司資料Corporate Profile4公司簡介Financial Highlights7財務概要Five-Year Financial Summary9五年財務摘要Chairmans Statement10主席報告Manag

2、ement Discussion and Analysis12管理層討論及分析Directors and Key Personnel Profiles24董事及主要人員履歷Report of the Directors32董事會報告Corporate Governance Report56企業管治報告Independent Auditors Report68獨立核數師報告Consolidated Statement of Profit or Loss77綜合損益表Consolidated Statement of Profit or Loss and Other Comprehensive I

3、ncome78綜合損益及其他全面收益表Consolidated Statement of Financial Position79綜合財務狀況表Consolidated Statement of Changes in Equity81綜合權益變動表Consolidated Statement of Cash Flows83綜合現金流量表Notes to the Consolidated Financial Statements85綜合財務報表附註Definition 226 釋義Lees Pharmaceutical Holdings Limited 李氏大藥廠控股有限公司2Corporate

4、 Information公司資料BOARD OF DIRECTORSExecutive DirectorsMs.Lee Siu Fong(Chairman)Ms.Leelalertsuphakun Wanee(Managing Director)Non-executive DirectorsDr.Li XiaoyiMr.James Charles GaleIndependent Non-executive DirectorsDr.Chan Yau Ching,BobMs.Cheang Yee Wah,Eva(appointed with effect from 17 May 2023)Mr.L

5、am Yat Cheong(resigned with effect from 17 May 2023)Dr.Tsim Wah Keung,KarlCOMPANY SECRETARYMr.Chow Yiu MingAUDIT COMMITTEEDr.Chan Yau Ching,Bob(Chairman)Ms.Cheang Yee Wah,Eva(appointed with effect from 17 May 2023)Mr.Lam Yat Cheong(resigned with effect from 17 May 2023)Dr.Tsim Wah Keung,KarlREMUNERA

6、TION COMMITTEEDr.Tsim Wah Keung,Karl(Chairman)Ms.Leelalertsuphakun WaneeDr.Chan Yau Ching,BobNOMINATION COMMITTEEMs.Lee Siu Fong(Chairman)Dr.Chan Yau Ching,BobDr.Tsim Wah Keung,KarlMANAGEMENT COMMITTEEMs.Leelalertsuphakun Wanee(Chairman)Ms.Lee Siu Fong董事會執行董事李小芳女士（主席）李燁妮女士（董事總經理）非執行董事李小羿博士James Char